|
Customer (a biomedical engeneer; not the end user) reported discrepant blood lead test results obtained from two different leadcare ii analyzers for the same patient.Quality controls were reported within range; however, specific control values and reagent lot information were not provided.The customer reported that the analyzer serial number: (b)(6) produced a blood lead test result of 8.3 g/dl, while a second leadcare ii analyzer produced a result of approximately 5.5 - 5.8 g/dl.The serial number for the second analyzer has not been provided.Technical support (ts) inquired whether repeat testing was performed using a newly collected patient sample or by using original sample leftover in the treatment reagent vial.Ts also asked whether confirmatory venous blood testing had been conducted on the patient.Ts requested end-user contact information.The customer indicated they would visit the end-user site on (b)(6) 2026 and obtain additional details.On (b)(6) 2026, the customer reported that the testing site supervisor was unsure whether the second test result was obtained from a recollected sample or a rerun of the original in the treatment regent vial.The sample was reportedly retested due to the initial elevated result; the site indicated that routine reruns are not typically performed.Follow up attempts by ts: 03/18/2026: requested additional information via email.03/23/2026: voicemail left.03/30/2026: follow-up email requesting end-user contact information.On (b)(6) 2026, the customer reported they are attempting to have a clinic representative contact ts or provide a direct phone number for follow-up.
|